Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00445458
Status:
COMPLETED
Last Update Posted:
2018-07-26
First Post:
2007-03-08
Brief Title:
A Phase 12 Study of HKI-272 Neratinib in Combination With Paclitaxel Taxol in Subjects With Solid Tumors and Breast Cancer
Sponsor:
Puma Biotechnology Inc
Organization:
Puma Biotechnology Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-07
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-08
First Submit QC Date:
March 8 2007
Study First Post Date:
2007-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-05-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-01-29
Disp First Submit QC Date:
January 29 2013
Disp First Post Date:
2013-01-31
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-06-27
Last Update Post Date:
2018-07-26
Last Update Post Date Type:
ACTUAL